Paper published in a journal (Scientific congresses and symposiums)
The risk of subsequent osteoporotic fractures is decreased in patients experiencing fracture while on denosumab: results from the FREEDOM and FREEDOM Extension studies.
Kendler, D.L.; Chines, A.; Brandi, M.L. et al.
2017In Osteoporosis International, 28 Suppl 1, p. 174-175
Peer Reviewed verified by ORBi
 

Files


Full Text
The risk of subsequent osteoporotic fractures is decreased in patients experiencing fracture while on denosumab. results from the FREEDOM and FREEDOM Extension studies..pdf
Publisher postprint (1.12 MB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Disciplines :
General & internal medicine
Author, co-author :
Kendler, D.L.
Chines, A.
Brandi, M.L.
Papapoulos, S.
Lewiecki, E.M.
Reginster, Jean-Yves  ;  Université de Liège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Roux, C.
Munos-Torres, M.
Wang, A
Bone, H.G.
Language :
English
Title :
The risk of subsequent osteoporotic fractures is decreased in patients experiencing fracture while on denosumab: results from the FREEDOM and FREEDOM Extension studies.
Publication date :
March 2017
Event name :
World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
Event organizer :
WCO-IOF-ESCEO
Event place :
Florence, Italy
Event date :
du 23 au 26 mars 2017
Audience :
International
Journal title :
Osteoporosis International
ISSN :
0937-941X
eISSN :
1433-2965
Publisher :
Springer Science & Business Media B.V., Godalming, United Kingdom
Volume :
28 Suppl 1
Pages :
174-175
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 19 July 2017

Statistics


Number of views
77 (3 by ULiège)
Number of downloads
3 (3 by ULiège)

Bibliography


Similar publications



Contact ORBi